Fig. 1
From: Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study
Hazard ratios (95% CIs) for matched inhaled corticosteroid (ICS) vs. long-acting bronchodilator (LABD) initiators, all patients and stratified by GOLD group, for a diabetes onset, b diabetes progression, and c osteoporosis onset (See Methods section for lists of variables used for adjustment in the outcome models.)
